Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Sales, net	$ 10,304	$ 9,770
Cost of sales	9,085	8,765
Gross profit	1,219	1,005
Selling and administrative expenses	814	794
Operating income	405	211
Other income (expense), net:
Interest expense	(200)	(233)
Change in fair value of derivative liabilities	9	(118)
Impairment on investment in iBio, Inc.		(83)
Total other expense, net	(191)	(434)
Income (loss) before income taxes	214	(223)
Income tax expense (benefit), net	55	(44)
Net income (loss)	$ 159	$ (179)
Basic net income (loss) per common share (in dollars per share)	$ 0.01	$ (0.01)
Diluted net income (loss) per common share (in dollars per share)	$ 0.01	$ (0.01)
Weighted average common shares outstanding - basic (in shares)	27,218,786	21,135,174
Add: Equivalent shares outstanding - Stock Options (in shares)	744,818
Shares issuable upon conversion of Convertible Debt - CD Financial, LLC (in shares)	8,230,769
Weighted average common shares outstanding - diluted (in shares)	27,963,604	21,135,174